NCT04279535View on ClinicalTrials.gov

Topical Vitamin C for Treatment of Basal Cell Cancer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

March 1, 2019

Study Completion Date

June 1, 2019

Conditions
Basal Cell Carcinoma
Interventions
DRUG

Topical Ascorbic Acid

Twice daily application of 300 microliters of 30% ascorbic acid solution with a small cuticle brush.

Trial Locations (1)

83706

Center for Biomedical Research,Inc., Boise

All Listed Sponsors
lead

Center for Biomedical Research, Inc.

INDUSTRY

NCT04279535 - Topical Vitamin C for Treatment of Basal Cell Cancer | Biotech Hunter | Biotech Hunter